Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ENDRA Life Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
NDRA
Nasdaq
8731
https://www.endrainc.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript
- Apr 1st, 2024 1:59 pm
Q4 2023 ENDRA Life Sciences Inc Earnings Call
- Mar 29th, 2024 10:21 am
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 28th, 2024 8:05 pm
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
- Mar 21st, 2024 12:00 pm
ENDRA Life Sciences Installs First TAEUS System in the UK
- Feb 27th, 2024 1:00 pm
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
- Feb 21st, 2024 1:00 pm
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
- Feb 14th, 2024 1:30 pm
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
- Nov 29th, 2023 1:00 pm
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
- Nov 27th, 2023 1:00 pm
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript
- Nov 15th, 2023 6:23 pm
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
- Nov 14th, 2023 9:05 pm
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
- Nov 8th, 2023 1:00 pm
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
- Nov 7th, 2023 9:05 pm
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
- Nov 6th, 2023 1:00 pm
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
- Sep 7th, 2023 12:00 pm
ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
- Aug 30th, 2023 12:00 pm
ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
- Aug 23rd, 2023 12:00 pm
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript
- Aug 20th, 2023 3:20 pm
Q2 2023 ENDRA Life Sciences Inc Earnings Call
- Aug 15th, 2023 10:49 am
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
- Aug 14th, 2023 8:05 pm
Scroll